Lupin Recalls Testosterone Topical Solution Due to Pump Defects
Lupin Pharmaceuticals is recalling 3,200 bottles of Testosterone Topical Solution because the pump mechanism is not working.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences. The issue is a mechanical defect (pump not working) rather than a safety hazard like contamination or injury.
Plain-English summary
Lupin Pharmaceuticals Inc. is recalling 3,200 bottles of Testosterone Topical Solution, 30mg/1.5mL, 110mL bottles. The product is identified by Lot # K700086 and has an expiration date of 11/2019. The recall is due to repetitive complaints indicating that the pump is not working.
The recalled product was distributed to 7 major wholesale/drug chain distributors and 1 supermarket chain, which may have further distributed the product throughout the United States. The FDA has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for guidance on how to dispose of the medication or obtain a replacement.
The recalled product
- Product
- TESTOSTERONE (TESTOSTERONE)
- Brand
- TESTOSTERONE
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Category
- Drug — Topical Solution
- Hazard
- Affected units
- 3,200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # K700086
- Exp 11/2019
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · TESTOSTERONE
- ModerateTestosterone gel packets recalled over a side-seal defect allowing leakage
FDA (Drugs) · 2025-12-10
- HighTestosterone Gel Recalled Nationwide Due to Benzene Contamination
FDA (Drugs) · 2025-04-02
- HighStrides Pharma Testosterone Gel Recalled Due to Benzene Contamination
FDA (Drugs) · 2025-04-02
- HighTestosterone Gel Recalled by Teva for Excessive Potency
FDA (Drugs) · 2024-08-28
- ModerateTestosterone Gel Recalled for Out-of-Specification Viscosity
FDA (Drugs) · 2023-12-06
Same manufacturer · Lupin Pharmaceuticals Inc.
See all →- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- SevereGlucagon Emergency Kit Recalled for Manufacturing Process Deviation
FDA (Drugs) · 2026-07-08
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- ModerateSertraline tablets recalled because bottle seals are not adhering
FDA (Drugs) · 2025-12-17
Same hazard · defective container
See all →- High
- ModeratePureLife benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModeratePearson Quality benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateDental City benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateDHP benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24